Patents matching “formulation”

US 10751348

Formulations of testosterone and methods of treatment therewith

The Board of Regents of the University of Texas System · Granted Aug 25, 2020 · Expires Aug 20, 2040

US 10751408

Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

The Regents of the University of Colorado, a Body Corporate · Granted Aug 25, 2020 · Expires Aug 20, 2040

US 10752701

Stabilized formulations containing anti-PCSK9 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Aug 25, 2020 · Expires Aug 20, 2040

CA 3129357

FORMULATIONS PHARMACEUTIQUES LIQUIDES DE CONJUGUES PTH

ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Aug 20, 2020 · Expires Aug 15, 2040

US 10744144

Pharmaceutical formulation

Semnur Pharmaceuticals, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

US 10744154

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

GALECTIN THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

US 10738047

Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

US 10736859

Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

TONIX PHARMA LIMITED · Granted Aug 11, 2020 · Expires Aug 6, 2040

US 10729720

Peroxide formulations and methods and applicators for using the same

Aclaris Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

US 10729651

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

US 10722579

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

US 10716854

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

US 10716853

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

US 10716852

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

US 10716758

Liposomal statin formulation

Northwestern University · Granted Jul 21, 2020 · Expires Jul 16, 2040

US 10709665

Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

Pacira Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

US 10702576

Stable formulations of linaclotide

IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

US 10702473

Liposome formulation for delivery of Wnt signal pathway inhibitor

Curegenix, Inc. · Granted Jul 7, 2020 · Expires Jul 2, 2040

US 10695308

Inhalation formulations of treprostinil

United Therapeutics Corporation · Granted Jun 30, 2020 · Expires Jun 25, 2040

US 10695296

Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient

Asana BioSciences, LLC · Granted Jun 30, 2020 · Expires Jun 25, 2040

US 10688183

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

US 10682310

Therapeutic compounds and formulations for intranasal delivery

Regents of the University of Minnesota · Granted Jun 16, 2020 · Expires Jun 11, 2040

US 10675341

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

US 10675245

Sustained release formulation of a non-steroidal anti-inflammatory drug

Pacira Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040